Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1973 1
1975 2
1976 2
1977 1
1978 7
1979 5
1980 2
1981 1
1982 8
1983 4
1984 3
1985 3
1986 3
1987 3
1988 8
1989 8
1990 9
1991 7
1992 5
1993 7
1994 6
1995 3
1996 8
1997 5
1998 6
1999 8
2000 8
2001 6
2002 9
2003 9
2004 9
2005 13
2006 17
2007 18
2008 14
2009 10
2010 10
2011 6
2012 3
2013 12
2014 7
2015 12
2016 12
2017 7
2018 6
2019 5
2020 8
2021 11
2022 6
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Results by year

Filters applied: . Clear all
Page 1
Targeting the Hedgehog Pathway in Rhabdomyosarcoma.
Zarzosa P, Garcia-Gilabert L, Hladun R, Guillén G, Gallo-Oller G, Pons G, Sansa-Girona J, Segura MF, Sánchez de Toledo J, Moreno L, Gallego S, Roma J. Zarzosa P, et al. Among authors: pons g. Cancers (Basel). 2023 Jan 24;15(3):727. doi: 10.3390/cancers15030727. Cancers (Basel). 2023. PMID: 36765685 Free PMC article. Review.
Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
Lapeyre-Mestre M, Sapède C, Moore N; les participants à la table ronde N° 5 de Giens XXVIII :; Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, Plétan Y, Pons G, Verpillat P, Vigneau C. Lapeyre-Mestre M, et al. Among authors: pons g. Therapie. 2013 Jul-Aug;68(4):241-6. doi: 10.2515/therapie/2013037. Therapie. 2013. PMID: 27392726 French. No abstract available.
Vigabatrin. Clinical pharmacokinetics.
Rey E, Pons G, Olive G. Rey E, et al. Among authors: pons g. Clin Pharmacokinet. 1992 Oct;23(4):267-78. doi: 10.2165/00003088-199223040-00003. Clin Pharmacokinet. 1992. PMID: 1395360 Review.
Barcelona consensus on supermicrosurgery.
Masia J, Olivares L, Koshima I, Teo TC, Suominen S, Van Landuyt K, Demirtas Y, Becker C, Pons G, Garusi C, Mitsunaga N. Masia J, et al. Among authors: pons g. J Reconstr Microsurg. 2014 Jan;30(1):53-8. doi: 10.1055/s-0033-1354742. Epub 2013 Sep 13. J Reconstr Microsurg. 2014. PMID: 24037459
Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma.
Espinosa-Sotelo R, Fusté NP, Peñuelas-Haro I, Alay A, Pons G, Almodóvar X, Albaladejo J, Sánchez-Vera I, Bonilla-Amadeo R, Dituri F, Serino G, Ramos E, Serrano T, Calvo M, Martínez-Chantar ML, Giannelli G, Bertran E, Fabregat I. Espinosa-Sotelo R, et al. Among authors: pons g. Redox Biol. 2023 Sep;65:102818. doi: 10.1016/j.redox.2023.102818. Epub 2023 Jul 13. Redox Biol. 2023. PMID: 37463530 Free PMC article.
A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.
Pons G, Riba D, Casasampere M, Izquierdo E, Abad JL, Fabriàs G, Rodríguez Ortega PG, López-González JJ, Montejo M, Casas J, Delgado A. Pons G, et al. J Org Chem. 2020 Jan 17;85(2):419-429. doi: 10.1021/acs.joc.9b02420. Epub 2020 Jan 3. J Org Chem. 2020. PMID: 31860798
Pharmacoepidemiology studies: what levels of evidence and how can they be reached?
Lapeyre-Mestre M, Sapède C, Moore N; participants of round table N° 5 of Giens Workshops XXVIII (th); Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, Plétan Y, Pons G, Verpillat P, Vigneau C. Lapeyre-Mestre M, et al. Among authors: pons g. Therapie. 2013 Jul-Aug;68(4):241-52. doi: 10.2515/therapie/2013038. Epub 2013 Aug 28. Therapie. 2013. PMID: 23981262 Free article. English, French.
328 results